Aktienanalyse zu Estee Lauder Companies Inc (EL)ELEstee Lauder Companies Inc

The Estee Lauder Companies Inc. is a manufacturer, marketer and seller of skin care, makeup, fragrance and hair care products. Its products are sold in over 150 countries and territories under a number of brand names, including Estee Lauder, Aramis, Clinique, Lab Series, Origins, M.A.C, Bobbi Brown Cosmetics, La Mer, Aveda, Jo Malone London, Bumble and bumble, Darphin Paris, TOM FORD, Smashbox, AERIN Beauty, Le Labo, Editions de Parfums Frederic Malle, GLAMGLOW, Kilian Paris, Too Faced, Dr.Jart+, and the DECIEM family of brands, including The Ordinary and NIOD, and BALMAIN Beauty. It is a license for fragrances, cosmetics and/or related products for AERIN, BALMAIN, and Dr. Andrew Weil. Its skin care products include moisturizers, serums, cleansers, toners, exfoliators, facial masks, body care, sun care products and others. Its makeup products include foundations, powders, concealers and setting sprays, lipsticks, lip liners and lip glosses, and mascaras, eyeshadows and eyeliners. It operates in the Consumer Non-Cyclicals sector (PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS industry).

Estee Lauder is a good buy right now, with a current price of $98.05 and a forward P/E ratio of 29.76, indicating potential for growth. The stock has shown a recent 5-day change of +6.61%, suggesting positive momentum. However, the main risk is the high P/E ratio of 187.77, which could indicate overvaluation if growth does not meet expectations.

24 analysts cover EL: 19 rate it Buy, 5 Hold and 0 Sell. The average price target is 106.76.